Gastrointestinal DiseaseGut healthDevice
What this study is
To develop novel optical imaging technologies for use as a non-destructive and minimally invasive tool for detection and diagnosis of various diseases that affect the gastrointestinal system.
What's being tested
- Biopsy imaged by Optical imaging device.
Intervention · DEVICE
Study details
- Sponsor
- Massachusetts General Hospital
- Conditions
- Gastrointestinal Disease · Gastrointestinal Dysfunction
- Enrolling
- 200 people
- Starts
- 2016-03-25
- Est. completion
- 2028-12-31
- Design
- Open-label, single group
- Record
- View on ClinicalTrials.gov ↗
Who can join
Age 18 Years and overSex ALLHealthy volunteers AcceptedYou may qualify if
- Scheduled for an elective esophagoduodenoscopy and/or colonoscopy
You can't join if
- According to standard of care at MGH endoscopy department.
Sign in and we'll check these against your records.Full criteria on ClinicalTrials.gov ↗
Loading treatment details…
1
Study locations (1)
1 openMassachusetts General Hospital
Boston, Massachusetts, United States
Study team
Sponsor
Massachusetts General Hospital
Study ID 2015P000328
Principal investigator
Guillermo Tearney, M.D, PhD.
Massachusetts General Hospital
Have questions? The record lists no central contact. Use Consider me and the site team can reach you, or find them through ClinicalTrials.gov ↗.
Frequently asked questions
The sponsor hasn't published answers to common questions for this trial.